NGB and breast carcinoma: In the future, the analysis of NGB levels in the serum of breast cancer patients, with respect to comparable healthy volunteers, could reinforce from one side the possibility that NGB can have an extracellular function and from the other that, beyond the tissue levels of NGB, the amount of serum NGB can be used as a breast cancer biomarker with a prognostic value.